Jinla where are you getting your facts from?
The announcement last week stated the next trial will cost under $1.5m, and the company has those funds currently in the bank along with the imminent sale of the surgical business.
I cannot see the point of completing 2 more trials after the IIa results announced last week. It would be an uneccesary expense and delay the time to market. Give the management team a little more credit than that IMO
clyde r u still with us??, page-41
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.159M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 425293 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 230500 | 2 |
View Market Depth
| Last trade - 16.12pm 01/11/2024 (20 minute delay) ? |
| EMS (ASX) Chart |
Day chart unavailable